Marc Pretze

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Journal of labelled compounds & radiopharmaceuticals

EJNMMI radiopharmacy and chemistry

University Hospital Carl Gustav Carus, TU Dresden

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Carl Gustav Carus, TU Dresden Nov 01 2019

Germany

Research Assistant Professor :: Department of Nuclear Medicine

Medical Faculty Mannheim of Heidelberg University Jul 01 2013 - Oct 31 2019

Germany

Research Assistant Professor :: Molecular Imaging & Radiochemistry

Publications

Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Lisa Hübinger, Kerstin Wetzig, Roswitha Runge, Holger Hartmann, Falk Tillner, Katja Tietze, Marc Pretze, David Kästner, Robert Freudenberg, Claudia Brogsitter, Jörg Kotzerke
Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations. Pharmaceutics 16 (4) (2024)
Lisa Hübinger, Kerstin Wetzig, Roswitha Runge, Holger Hartmann, Falk Tillner, Katja Tietze, Marc Pretze, David Kästner, Robert Freudenberg, Claudia Brogsitter, Jörg Kotzerke
Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations. Pharmaceutics 16 (4) (2024)
Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Marc Pretze, Enrico Michler, Roswitha Runge, Kerstin Wetzig, Katja Tietze, Florian Brandt, Michael K Schultz, Jörg Kotzerke
Influence of the Molar Activity of 203/212 Pb-PSC-PEG 2 -TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Marc Pretze, Laura Reffert, Steffen Diehl, Stefan O Schönberg, Carmen Wängler, Peter Hohenberger, Björn Wängler
GMP-compliant production of [68Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor. EJNMMI radiopharmacy and chemistry 6 (1) (2021)
Marc Pretze, Falk Kunkel, Roswitha Runge, Robert Freudenberg, Anja Braune, Holger Hartmann, Uwe Schwarz, Claudia Brogsitter, Jörg Kotzerke
Ac-EAZY! Towards GMP-Compliant Module Syntheses of 225Ac-Labeled Peptides for Clinical Application. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Marc Pretze, Christin Neuber, Elisa Kinski, Birgit Belter, Martin Köckerling, Amedeo Caflisch, Jörg Steinbach, Jens Pietzsch, Constantin Mamat
Synthesis, radiolabelling and initial biological characterisation of 18F-labelled xanthine derivatives for PET imaging of Eph receptors. Organic & biomolecular chemistry 18 (16) (2020)
Marc Pretze, Nick P van der Meulen, Carmen Wängler, Roger Schibli, Björn Wängler
Targeted 64 Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. Journal of labelled compounds & radiopharmaceuticals 62 (8) (2019)
Marc Pretze, Andreas Hien, Matthias Rädle, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging. Bioconjugate chemistry 29 (5) (2018)
Andreas Hien, Marc Pretze, Frank Braun, Edgar Schäfer, Tim Kümmel, Mareike Roscher, Daniel Schock-Kusch, Jens Waldeck, Bernhard Müller, Carmen Wängler, Matthias Rädle, Björn Wängler
Noncontact recognition of fluorescently labeled objects in deep tissue via a novel optical light beam arrangement. PloS one 13 (12) (2018)
Prama Pallavi, Marc Pretze, Julio Caballero, Yingchun Li, Björn B Hofmann, Eleni Stamellou, Sarah Klotz, Carmen Wängler, Björn Wängler, Ralf Loesel, Steffen Roth, Bastian Theisinger, Handan Moerz, Uta Binzen, Wolfgang Greffrath, Rolf-Detlef Treede, Martin C Harmsen, Bernhard K Krämer, Mathias Hafner, Benito A Yard, Anna-Isabelle Kälsch
Analyses of Synthetic N-Acyl Dopamine Derivatives Revealing Different Structural Requirements for Their Anti-inflammatory and Transient-Receptor-Potential-Channel-of-the-Vanilloid-Receptor-Subfamily-Subtype-1 (TRPV1)-Activating Properties. Journal of medicinal chemistry 61 (7) (2018)

Marc Pretze.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Pretze